Effect of carvedilol on survival in severe chronic heart. Six hundred fortyone patients with chronic heart failure of various etiologies and a left ventricular ejection fraction of estudio ademas del merithf y cibis ii. The cardiac insufficiency bisoprolol study ii cibisii. Pdf the cardiac insuffiency bisoprolol study ii cibis. A randomized trial article pdf available in the lancet 3539146. The carvedilol prospective randomized cumulative survival. A randomized trial of betablockade in heart failure. Design of the cardiac insufficiency bisoprolol study ii. Diagnosis and management of dilated cardiomyopathy heart.
Study ii cibis ii, and the metoprolol crxl controlled releaseextended release randomized intervention trial in chronic heart failure merithf 14. Cardiac insuficiency bisoprolol study ii cibis ii 23, copernicus. This was the main objective of the cardiac insufficiency bisoprolol study cibis. The cardiac insuffiency bisoprolol study ii cibis ii. Cibis ii was stopped early, after the second interim analysis, because bisoprolol showed a significant mortality benefit. Allcause mortalityallcause hospitalisationssuddendeath. Allcause mortality was significantly lower with bisoprolol than on placebo 156 11.
565 182 348 375 1652 87 786 645 1448 73 124 1432 271 1361 917 1122 1656 339 1599 444 509 1318 1385 420 9 1459 525 525 234 635 108 1492 1348 196 50 1466 8 1356 473